JTE907

CAS No. 282089-49-0

JTE907 ( JTE-907;JTE 907 )

Catalog No. M13857 CAS No. 282089-49-0

A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 Get Quote
10MG 177 Get Quote
25MG 312 Get Quote
50MG 464 Get Quote
100MG 662 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JTE907
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively.
  • Description
    A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively; increases of forskolin-stimulated cAMP production in CHO cells expressing CB2 in vitro, inhibits carrageenin-induced mouse paw edema dose dependently in mice.
  • Synonyms
    JTE-907;JTE 907
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    282089-49-0
  • Formula Weight
    438.48
  • Molecular Formula
    C24H26N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CC2=C(NC1=O)C(OCCCCC)=C(OC)C=C2)NCC3=CC=C(OCO4)C4=C3
  • Chemical Name
    N-(1,3-Benzodioxol-5-ylmethyl)-1,2-dihydro-7-methoxy-2-oxo-8-(pentyloxy)-3-quinolinecarboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Iwamura H, et al. J Pharmacol Exp Ther. 2001 Feb;296(2):420-5.
2. Ueda Y, et al. Eur J Pharmacol. 2005 Sep 27;520(1-3):164-71.
3. Maekawa T, et al. Eur J Pharmacol. 2006 Aug 7;542(1-3):179-83.
molnova catalog
related products
  • NESS-0327

    A potent, selective CB1 cannabinoid receptor antagonist with Ki of 350 fM.

  • Anandamide

    Anandamide, an immune modulator, acts via not only cannabinoid receptors (CB1 and CB2) but also other targets (e.g., GPR18/GPR55) in the central nervous system.

  • Otenabant hydrochlor...

    A potent, and selective CB1 receptor antagonist with Ki of 0.7 nM/0.12 nM in binding and functional assays respectively.